CN115803450A - 特应性皮炎的重症度的检测方法 - Google Patents

特应性皮炎的重症度的检测方法 Download PDF

Info

Publication number
CN115803450A
CN115803450A CN202180049268.2A CN202180049268A CN115803450A CN 115803450 A CN115803450 A CN 115803450A CN 202180049268 A CN202180049268 A CN 202180049268A CN 115803450 A CN115803450 A CN 115803450A
Authority
CN
China
Prior art keywords
severity
gene
atopic dermatitis
expression
expression level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180049268.2A
Other languages
English (en)
Chinese (zh)
Inventor
高田直人
桑野哲矢
井上高良
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Publication of CN115803450A publication Critical patent/CN115803450A/zh
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders
    • G01N2800/202—Dermatitis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CN202180049268.2A 2020-07-10 2021-07-09 特应性皮炎的重症度的检测方法 Pending CN115803450A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020119040 2020-07-10
JP2020-119040 2020-07-10
PCT/JP2021/025988 WO2022009988A1 (ja) 2020-07-10 2021-07-09 アトピー性皮膚炎の重症度の検出方法

Publications (1)

Publication Number Publication Date
CN115803450A true CN115803450A (zh) 2023-03-14

Family

ID=79552561

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180049268.2A Pending CN115803450A (zh) 2020-07-10 2021-07-09 特应性皮炎的重症度的检测方法

Country Status (5)

Country Link
US (1) US20230265515A1 (cg-RX-API-DMAC7.html)
EP (1) EP4180536A4 (cg-RX-API-DMAC7.html)
JP (1) JP7743217B2 (cg-RX-API-DMAC7.html)
CN (1) CN115803450A (cg-RX-API-DMAC7.html)
WO (1) WO2022009988A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115279901A (zh) * 2020-03-11 2022-11-01 花王株式会社 来自皮肤表面脂质的rna的制备方法
WO2024232368A1 (ja) * 2023-05-08 2024-11-14 花王株式会社 アトピー性皮膚炎の重症度の検出方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101818672B1 (ko) * 2017-02-17 2018-01-16 가천대학교 산학협력단 아토피 피부염 진단용 조성물 및 상기 조성물을 이용한 아토피 피부염의 진단 방법
WO2018161062A1 (en) * 2017-03-03 2018-09-07 Children's Hospital Medical Center Non-invasive methods for skin sample collection and analysis
US20180325938A1 (en) * 2016-03-25 2018-11-15 Kao Corporation Method of evaluating or selecting androgen receptor activity regulator selective to sebaceous glands or hair follicles
WO2020091044A1 (ja) * 2018-11-01 2020-05-07 花王株式会社 被験体の皮膚細胞に由来する核酸の調製方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005100602A (ja) * 2003-08-26 2005-04-14 Matsushita Electric Ind Co Ltd 記録媒体の原盤製造方法、スタンパ製造方法、記録媒体製造方法、記録媒体の原盤、記録媒体のスタンパ、記録媒体
JP6231252B1 (ja) 2016-07-08 2017-11-15 花王株式会社 核酸試料の調製方法
WO2021221138A1 (ja) * 2020-05-01 2021-11-04 花王株式会社 アトピー性皮膚炎の検出方法
WO2021230379A1 (ja) * 2020-05-14 2021-11-18 花王株式会社 パーキンソン病の検出方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180325938A1 (en) * 2016-03-25 2018-11-15 Kao Corporation Method of evaluating or selecting androgen receptor activity regulator selective to sebaceous glands or hair follicles
KR101818672B1 (ko) * 2017-02-17 2018-01-16 가천대학교 산학협력단 아토피 피부염 진단용 조성물 및 상기 조성물을 이용한 아토피 피부염의 진단 방법
WO2018161062A1 (en) * 2017-03-03 2018-09-07 Children's Hospital Medical Center Non-invasive methods for skin sample collection and analysis
WO2020091044A1 (ja) * 2018-11-01 2020-05-07 花王株式会社 被験体の皮膚細胞に由来する核酸の調製方法

Also Published As

Publication number Publication date
WO2022009988A1 (ja) 2022-01-13
US20230265515A1 (en) 2023-08-24
JP7743217B2 (ja) 2025-09-24
JP2022016416A (ja) 2022-01-21
EP4180536A1 (en) 2023-05-17
EP4180536A4 (en) 2024-08-07

Similar Documents

Publication Publication Date Title
CN109477145A (zh) 炎症性肠病的生物标志物
JP7849812B2 (ja) パーキンソン病の検出方法
US10793911B2 (en) Host DNA as a biomarker of Crohn's disease
JP7743217B2 (ja) アトピー性皮膚炎の重症度の検出方法
JP7743239B2 (ja) 乳幼児アトピー性皮膚炎の検出方法
JP7762549B2 (ja) アトピー性皮膚炎の症度変化の検出方法
JP7743475B2 (ja) アトピー性皮膚炎の検出方法
JP7743289B2 (ja) アトピー性皮膚炎の症度の検出方法
JP7767500B2 (ja) アトピー性皮膚炎の重症度の検出方法
JP7743474B2 (ja) 乳幼児アトピー性皮膚炎の検出方法
JP7847450B2 (ja) アトピー性皮膚炎の症度悪化の検出方法
CN114480636A (zh) 胆汁细菌作为肝门部胆管癌诊断及预后标志物的用途
JP7847451B2 (ja) アトピー性皮膚炎による皮膚痒みの症度悪化の検出方法
JP7750481B2 (ja) 内臓脂肪面積の検出方法
JP2023073134A (ja) ホットフラッシュの検出方法
JP2023073135A (ja) 更年期障害の重症度の検出方法
JP2023048810A (ja) 慢性ストレスレベルの検出方法
JP2023048811A (ja) 疲労の検出方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination